Jin Medical International Ltd. ZJYL
Industrial Specialties · IPO 2023 · data as of November 13, 2026
Jin Medical International Ltd. (ZJYL) is a healthcare company listed in the US with a market value of about $554M. In the twelve months to March 31, 2026 it had revenue of $20M and net income of $1M, a net margin of 5.9%.
Its overall Stock Analiz score is 1.4 out of 5 (weak). The strongest part is financial health (3/5); the weakest is shareholder returns (0/5).
Key numbers: a P/E of 18.4, a 5-year average ROIC of 10%.
About Jin Medical International
Jin Medical International is listed in the US and classified in industrial specialties, IPO year 2023. Revenue went from $21M in 2021 to $21M in 2025, a decline of about 0.1% a year. It was profitable in 5 of the last 5 years in our data. It spends 8% of revenue on research and development.
Score: 1.4 / 5
Checks passed
- P/E below 25
- P/E below the industry median
- Strong R&D investment or growth above 20%
- Profitable 5 years in a row
- More cash than debt, or low debt to equity
- Interest covered more than 5 times
- Liabilities below 60% of assets
Checks not passed
- P/FCF below 20
- Price below intrinsic value (DCF, moderate assumptions)
- PEG below 1.5
- Revenue growth above 10% last year
- 3-year revenue growth above 10% a year
- Profit margin improving
- 3-year free cash flow growth above 10% a year
- 5-year EPS growth above 10% a year
Valuation
Growth and quality
Financials, last 5 years
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Revenue | $20M | $21M | $24M | $20M | $19M | $21M |
| Net income | $1M | $1M | $4M | $3M | $3M | $3M |
| Free cash flow | -$7M | -$4M | -$1M | $3M | $2M | $6M |
| EPS (diluted) | $0.01 | $0.01 | $0.02 | $0.02 | $0.02 | $0.02 |
| Net margin | 5.9% | 5.8% | 15.6% | 14.5% | 14.1% | 12.7% |
| ROIC | — | 1.1% | 7.4% | 9.1% | 13.8% | 17.1% |
From the company’s 10-K and 10-Q filings with the SEC. TTM = trailing twelve months.
Frequently asked questions
What is Jin Medical International’s P/E ratio?
About 18.4, based on the last twelve months of diluted earnings per share.
Does Jin Medical International pay a dividend?
Not currently.
Is Jin Medical International a good stock to buy?
We do not give buy or sell advice. Jin Medical International scores 1.4 out of 5 on our five checks (value, growth, track record, financial health and shareholder returns); the checks above show why.
Similar companies
Generated from SEC filings, analyst consensus estimates and market prices, rebuilt every day. Educational information, not investment advice.